BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6358050)

  • 1. Applications of bioreactors in medicine.
    Callegaro L; Denti E
    Int J Artif Organs; 1983 Jul; 6 Suppl 1():107-10. PubMed ID: 6358050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An extracorporeal chamber for hemoperfusion with selective effect].
    Hydén H
    Lakartidningen; 1978 Jun; 75(24):2377-80. PubMed ID: 353403
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective detoxification: hemoperfusion on antiphenobarbital antibody immobilized on solid phase.
    Callegaro L; Barbieri U; Denti E
    Trans Am Soc Artif Intern Organs; 1981; 27():566-9. PubMed ID: 7331132
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of immobilized L-asparaginase in acrylic microparticles in an extracorporeal hollow-fiber dialyzer.
    Edman P; Nylén U; Sjöholm I
    J Pharmacol Exp Ther; 1983 Apr; 225(1):164-7. PubMed ID: 6834269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hollow fiber immobilized L-asparaginase: in vivo and in vitro immunological studies.
    Callegaro L; Assone F; Cecconato E; Malinverni A; Pasteris V; Rossi V
    Int J Artif Organs; 1983 Mar; 6(2):91-6. PubMed ID: 6840898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new extracorporeal reactor-dialyzer for enzyme therapy using immobilized L-asparaginase.
    Jackson JA; Halvorson HR; Furlong JW; Lucast KD; Shore JD
    J Pharmacol Exp Ther; 1979 May; 209(2):271-4. PubMed ID: 439002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme therapy and immuno-adsorption by an extra-corporeal device.
    Hydén H
    Biomater Med Devices Artif Organs; 1980; 8(1):1-11. PubMed ID: 6988019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis membranes containing asparaginase entrapped in microparticles.
    Edman P; Nylén U; Sjöholm I
    Methods Enzymol; 1988; 137():491-6. PubMed ID: 3163764
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of immobilized enzymes in detoxification. II. Immobilization and characterization of enzymes on hollow fiber devices].
    Mazzola G; Cremonesi P; Colombi S; Vecchio G; Agnellini D; Pietta PG
    Minerva Nefrol; 1979; 26(2):185-7. PubMed ID: 471347
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical applications of immobilized proteins, enzymes, and cells.
    Chang TM
    Methods Enzymol; 1988; 137():444-57. PubMed ID: 3374352
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic characterization of extracorporeal therapy.
    Pedersen H; Horváth C
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):437-54. PubMed ID: 7153874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E. coli K-12 asparaginase-based asparagine biosensor for leukemia.
    Verma N; Kumar K; Kaur G; Anand S
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(4):449-56. PubMed ID: 17701490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High molecular weight L-asparaginase derivatives based on a water-soluble carboxymethyl cellulose: biological properties].
    Karsakevich AS; Kinstler OB; Dauvarte AZh; Vina IA
    Vopr Med Khim; 1988; 34(3):107-10. PubMed ID: 3420797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of immobilized enzymes in detoxification. I. Study on the physical characteristics of the membrane as a function of the immobilization process].
    Baldini G; Masserini G; Pietta PG; Cremonesi P; Mazzola G; Vecchio G
    Minerva Nefrol; 1979; 26(2):181-4. PubMed ID: 471346
    [No Abstract]   [Full Text] [Related]  

  • 15. Immobilization and characterization of L-asparaginase on hollow fibers.
    Mazzola G; Vecchio G
    Int J Artif Organs; 1980 Mar; 3(2):120-3. PubMed ID: 7364507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mathematical modeling of flow-tube extracorporeal shunts with immobilized enzymes].
    Bulygin AN; Klesov AA; Roshchin SA; Bulygina LA; Pasechnik VA
    Prikl Biokhim Mikrobiol; 1984; 20(2):230-5. PubMed ID: 6546990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant asparaginase-based asparagine biosensor for leukemia.
    Kumar K; Kataria M; Verma N
    Artif Cells Nanomed Biotechnol; 2013 Jun; 41(3):184-8. PubMed ID: 22991930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].
    Zhou J; Jin H; Li Y; Jiang T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion trials with a collagen-immobilized enzyme in an extracorporeal reactor: activity, stability, and biocompatibility.
    Olanoff LS; Venkatasubramanian K; Bernath FR; Joyeuse R
    J Biomed Mater Res; 1977 Jan; 11(1):125-36. PubMed ID: 845182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrylic microspheres in vivo V: Immunological properties of immobilized asparaginase in microparticles.
    Edman P; Sjöholm I
    J Pharm Sci; 1982 May; 71(5):576-80. PubMed ID: 6212669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.